Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 6, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Generic treprostinil sodium + Standard of Care (Double Oral)

Treprostinil (prostacyclin analogue) solution for continuous subcutaneous (SC) or intravenous (IV) infusion (1 mg/ml; 2.5 mg/ml; 5 mg/ml; 10 mg/ml in 10 mL glass vial) will be administered by an infusion pump system and up-titrated to ≥40 ng/kg/min or to the maximum tolerated dose within 24 weeks. Further up-titration shall be performed until trial completion according to the discretion of the investigator.

DRUG

Standard of Care - Double Oral

All patients will receive standard of care double oral background treatment consisting of one Phosphodiesterase type 5 inhibitor (i.e., tadalafil or sildenafil) and one Endothelin Receptor Antagonist (i.e. ambrisentan, bosentan or macitentan)

Trial Locations (19)

Unknown

RECRUITING

Ordensklinikum Linz, Linz

RECRUITING

Medical University Vienna, Vienna

NOT_YET_RECRUITING

Fakultní Nemocnice Olomouc, Olomouc

NOT_YET_RECRUITING

Všeobecná fakultní nemocnice v Praze, Prague

NOT_YET_RECRUITING

Hôpital Bicêtre-- Assistance Publique Hopitaux de Paris, Paris

NOT_YET_RECRUITING

Hôpitaux Universitaires de Strasbourg, Strasbourg

NOT_YET_RECRUITING

DRK Kliniken Berlin Westend, Berlin

NOT_YET_RECRUITING

University Hospital Carl Gustav Carus of Technical University Dresden, Dresden

NOT_YET_RECRUITING

Universitätsmedizin Greifswald, Greifswald

NOT_YET_RECRUITING

Gottsegen National Cardiovascular lnstitute, Budapest

NOT_YET_RECRUITING

Medical University of Szeged, Szeged

RECRUITING

Sapienza University of Rome, Rome

NOT_YET_RECRUITING

John Paul II Hospital Krakow, Krakow

NOT_YET_RECRUITING

Fryderyk Chopin Hospital in European Health Centre Otwock, Otwock

NOT_YET_RECRUITING

Centro Hospitalar Lisboa Norte - Santa Maria University Hospital, Lisbon

NOT_YET_RECRUITING

Emergency Institute for Cardiovascular Diseases Prof. Dr. C.C.Iliescu, Bucharest

NOT_YET_RECRUITING

Emergency Clinical County Hospital of Targu Mures, Târgu Mureş

NOT_YET_RECRUITING

Hospital Clinic of Barcelona, Barcelona

NOT_YET_RECRUITING

Hospital Ramon y Cajal, Madrid

All Listed Sponsors
collaborator

ANOVA CRO s.r.o.

UNKNOWN

collaborator

PharmaLex Belgium

UNKNOWN

collaborator

Aixial s.r.o.

UNKNOWN

collaborator

GCP-Service International Ltd. & Co. KG

INDUSTRY

lead

AOP Orphan Pharmaceuticals AG

INDUSTRY

NCT06317805 - Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients | Biotech Hunter | Biotech Hunter